Alissa Hsu Lynch - 01 Jun 2023 Form 4 Insider Report for Pulmonx Corp (LUNG)

Reporting relationship: Director
Issuer ticker: LUNG
Reported as of: 01 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2023, 18:42:55 UTC
Prior SEC filing: 01 Dec 2022
Next SEC filing: 12 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Lauren Cristina, Attorney-in-Fact for Alissa Hsu Lynch

Key filing fact

Alissa Hsu Lynch filed Form 4 for Pulmonx Corp (LUNG) on 02 Jun 2023.

Key facts

This page summarizes Alissa Hsu Lynch's Form 4 filing for Pulmonx Corp (LUNG).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jun 2023, 18:42.

Change

Previous filing in this sequence was filed on 01 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LUNG transaction

Common Stock

Award

Transaction value: $0
Shares: +12,620
Change %: +106%
Price: $0.000000
Shares after: 24,530
Date: 01 Jun 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2023, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.